Sulfhydryl Cross-linked Targeted Gene Delivery
Sulfhydryl Cross-linked Targeted Gene Delivery
批准号:
6829646
负责人:
KEVIN G RICE
金额:
$22.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-01 至 2006-12-31
中文摘要
超出提供的空间。这项研究将探索一种新的基因递送系统,它是基于多肽DNA缩合物中的巯基交联物的形成。正在研究的基因递送系统是一种多组分肽缩合DNA制剂。主要成分是由缩合的多肽结合物缩合而成的DNA,每个多肽结合物都含有多个巯基,当结合到DNA上时,这些巯基可以自发聚合和交联。跟随静脉注射。剂量,交联的DNA缩合物被建议在循环期间和靶细胞内瞬时稳定质粒DNA。交联肽将与单个聚乙二醇链共价衍生,在DNA凝聚物表面形成空间层,阻止蛋白质结合,并掩盖网状内皮系统对DNA凝聚物的识别。通过将交联肽与单个N-糖衍生物进行衍生化,得到直接靶向肝细胞上的去唾液酸糖蛋白受体或库普弗细胞上的甘露糖受体的糖多肽,从而实现靶向性。DNA缩合物将使用交联糖肽和聚乙二醇肽的二元加成混合物来制备。交联肽将被修饰以缓冲内体,并允许DNA凝聚体释放到靶细胞的胞浆中。一旦进入胞浆,交联的DNA缩合物被认为是在二硫键还原后缓慢释放质粒DNA。需要检验的中心假设是,增加DNA凝聚体的稳定性并控制DNA释放到胞浆中的速度将延长DNA的半衰期,并在体内产生更高水平的基因表达。这些研究旨在利用一种新的化学机制系统地优化体内瞬时基因表达水平,以克服目前限制非病毒基因递送系统效率的障碍。表演网站========================================Section End===========================================
英文摘要
EXCEED THE SPACE PROVIDED. This study will investigate a novel gene delivery system that is based on the formation of sulfhydryl cross- links within peptide DNA condensates. The gene delivery system under investigation is a multi-component peptide condensed DNA formulation. The key components consist of plasmid DNA condensed by an add- mixture of peptide conjugates each containing multiple sulfhydryl groups designed to spontaneously polymerize and cross-link when bound to DNA. Following i.v. dosing, cross-linked DNA condensates are proposed to transiently stabilize plasmid DNA during circulation and inside the target cells. Cross-linking peptides will be covalently derivatized with a single polyethylene glycol (PEG) chain to form a steric layer on the surface of DNA condensates that blocks protein binding and masks DNA condensate recognition by the reticuloendothelial system. Targeting specificity will be achieved by derivatizing a cross-linking peptide with a single N-glycan resulting in glycopeptides that direct targeting to either the asialoglycoprotein receptor on hepatocytes or the mannose receptor on Kupffer cells. DNA condensates will be prepared using binary add- mixtures of cross-linking glycopeptide and PEG-peptide. Cross-linking peptides will be modified to buffer endosomes and allow DNA condensates to release into the cytosol of target cells. Once in the cytosol, cross- linked DNA condensates are proposed to slowly release plasmid DNA following disulfide bond reduction. The central hypothesis to be tested is that increasing DNA condensate stability and controlling the rate of DNA release into the cytosol will prolong the half-life of DNA and produce higher levels of gene expression in vivo. These studies aim to systematically optimize the level of transient gene expression in vivo using a novel chemical mechanism to overcome barriers that currently limit the efficiency of nonviral gene delivery systems. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Double Stranded mRNA Nanoparticles
-
批准号:9335928
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2016
-
负责人:KEVIN G RICE
-
依托单位:
Targeted Double Stranded mRNA Nanoparticles
-
批准号:9523296
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2016
-
负责人:KEVIN G RICE
-
依托单位:
Polyacridine Peptide Mediated Gene Targeting
-
批准号:8193314
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2011
-
负责人:KEVIN G RICE
-
依托单位:
Polyacridine Peptide Mediated Gene Targeting
-
批准号:8306000
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2011
-
负责人:KEVIN G RICE
-
依托单位:
Polyacridine Peptide Mediated Gene Targeting
-
批准号:8447530
-
项目类别:
-
资助金额:$27.39万
-
财政年份:2011
-
负责人:KEVIN G RICE
-
依托单位:
High Throughput Drug Screening Robot
-
批准号:7839322
-
项目类别:
-
资助金额:$72.97万
-
财政年份:2011
-
负责人:KEVIN G RICE
-
依托单位:
Polyacridine Peptide Mediated Gene Targeting
-
批准号:8628847
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2011
-
负责人:KEVIN G RICE
-
依托单位:
RAMP Mediated Gene Delivery
-
批准号:7896643
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2009
-
负责人:KEVIN G RICE
-
依托单位:
RAMP Mediated Gene Delivery
-
批准号:8116557
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2009
-
负责人:KEVIN G RICE
-
依托单位:
RAMP Mediated Gene Delivery
-
批准号:8307721
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2009
-
负责人:KEVIN G RICE
-
依托单位:
Proteosome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:7039140
-
项目类别:
-
资助金额:$21.61万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Proteosome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:7474879
-
项目类别:
-
资助金额:$4.57万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Proteosome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:7279038
-
项目类别:
-
资助金额:$4.55万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Proteosome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:7213374
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Proteosome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:7390819
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Proteasome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:6925752
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Sulfhydryl Cross-linked Targeted Gene Delivery
-
批准号:6995363
-
项目类别:
-
资助金额:$21.61万
-
财政年份:2003
-
负责人:KEVIN G RICE
-
依托单位:
Sulfhydryl Cross-linked Targeted Gene Delivery
-
批准号:6691662
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2003
-
负责人:KEVIN G RICE
-
依托单位:
Sulfhydryl Cross-linked Targeted Gene Delivery
-
批准号:6562553
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2003
-
负责人:KEVIN G RICE
-
依托单位:
REGULATED OSTEOINDUCTIVE PLASMID GENE TRANSFER VIA GENE
-
批准号:2897232
-
项目类别:
-
资助金额:$30.5万
-
财政年份:1998
-
负责人:KEVIN G RICE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胰岛素样生长信号介导的肺巨噬细胞和上皮细胞cross-tolk通过核自噬参与慢性气道炎症形成的机制研究
-
批准号:JCZRYB202500229
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于NLRP3炎性小体与自噬Cross-talk探讨心康冲剂干预心肌纤维化的机制研究
-
批准号:2025JJ80174
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邹菊英
-
依托单位:
PKM2琥珀酰化修饰介导癌细胞与血小板间Cross-talk调控胆管癌侵袭转移的研究
-
批准号:JCZRYB202500379
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于破骨-成骨细胞Cross-Talk探讨内固定物存留对关节软骨退变的影响及补肾强骨治法的科学内涵
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
三痹汤激活线粒体自噬影响免疫细胞Cross talk延缓椎间盘退变的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王楠
-
依托单位:
多环芳烃(PAHs )介导的癌细胞和Th17细胞“cross-talk”所
致免疫抑制反应在胶质瘤增殖侵袭中的作用及毒理学机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
PGK1乙酰化修饰介导癌细胞与TAMs间Cross-talk调控胆囊癌EMT的研究
-
批准号:82373032
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:王剑明
-
依托单位:
线粒体ClpP激动剂通过铁死亡-免疫调控cross-talk治疗急性髓细胞白血病的机制研究
-
批准号:82370171
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴俣
-
依托单位:
生长激素受体通过脂肪酸介导的肝脏-脂肪Cross-talk影响脂质内稳态的研究
-
批准号:82370866
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴英杰
-
依托单位:
基于“cross-β折叠”结构形成理论解析面筋蛋白淀粉样纤维的形成机制
-
批准号:32372365
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:张慧娟
-
依托单位: